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INTRODUCTION
The possibility of

dest:~?oying

or weakening cancer

cells by the general or selective absorption of neutrons
l;>y

cells was first pointed qut by Locher in 1939 (1).

Boron or lithium atoms were suggested as the absorbing
~----=a,gent

sino e . they_w_e_gpo_d__a.c_o_ept_o:ros_of:_ne_utron$ ~- Neutt>o:n ____-~-~- _

capture by ei·cher boron or lithium atoms pt>oduoes high
The radiation· is localized and

energy alpha radiation.

confined to the

a:~ea:

of

bti:t"ort

or

lithium concentration

because the mean f'ree path of the alpha particl(\ls produced

is approximately equal to the diameter of-a single oell.
The nuclear reactions for boron and lithium are
as follows:

For lithiuxn:

Locher also pointed out that neutrons themselves
, ... , _ "

<

.,·.~

cause very little darnae;e to tissue, and th:us they are an
improve~ent

over X:•ray therapy in the treatment of_tumors•

He emphasized that X.. rays cause equal damage to both
'

'

healthy and cancerous tissue.

~

Thus the upper limit of

2

the x-ray treatment j.a directly dependant upon the skin.
damage done.

In 1940 the first successful use of bor·on as a
chemotherapeutic agent was reported by Iwuge:r> (2)ii

He

)?epo:rted that neoplastic cells .can be destroyed i,q,

v~VSl

<f··

if sufficient boron in some. sui table form. can be applied

to the tumor !D; vivo..

Zahl• Coopel? and Dunning (3)'. in

1940 a~so reported significant :tncrease. in tumor reg,ression
following neutron-beam
mouse
.
':, eXposure of transplantable
.
.

~nwoo:mas

workers

.

.

'

injected with boron and lithium oompoUil.diH
po,.n~ed.

These

out e_t that time that in o:rde:t'> to be

effective the boron or 11tb.i1lm m.ust be

loc~lbted

in the

tumor only and that the swrounding normal .tissue must be
:Cree of' the materials which would absorb neutronso::

At

that time such a localization was improbable.,
Localization of suitable neutron absorbers in
<Hmcerous tissue tve.s begun as early as ·1929 when Ludfox>d
(4) ;. DWM•Reynals (5) and others reported that certain

dyes,. when injected :I.nt;ravenously; would concentrate to

a greater degree in

tum~~ tissu<t~

than in normal tissue •.

In 1941; Zahl and Cooper- (6,7) substituted 'lithium for
sodium in various azo dyes

(e•·g~r

ponta:mi.ne sky blue,

trypan blue,. c ar:minic acid) and administered these
compounds. intravenously both into· mice having spontaneous·

mammary .tumors and mice bearing implanted tumors of
sarcoma l80.t·

Deposition. of ·twice as much lithium ln t;he

l
tumor as compared to the normal surrounding tissue resulted~·

Extensive, neutron•beam therapy with cancer patients
was cal.'t:ried out in 1948 by Stone ('a),' who. published data

on neutron therapy with two hundred and fifty patients •'
!n his studies he found that the survival :t?ate of patients

treated with fast neutrons was very discouraging.,

stone

pointed out that slow or thermal neutrons would be the
---

-----

-

- - - - -

only probable neutron thet>apy which could be applied to
humans.

By use of boron•lO,whioh has a greater capture

potential tor slow neutrons, the

effec~s

of fast neutrons

can be overcome.

Javids sweet and co•tvorlters (9 ,lo) in 1952 reported
that boron, adrain:tstll)toed intl?a.venously as borax solution,
concentrated in many :r•apidly growing brain tumors to more

than three times the extent that it does in normal brain
tissue.

subseqent studies (11) of the concentration

ratios between neoplasms and surrounding normal tissue
indicated,

however~

that boron•neutron therapy offered

little promise for treatment of malignant turaors othel" than
those o:t the brain.
The use of the neutron-boron•lO reaction in the
treatment of cancer was studied in
(12 h

1954

by F•a:r:r • et aJ.

They made their studies on ten patients with brain

tumors (glioblastoma); some of whom received a total ot
four irradiation treatments given at five to six weeks
intervals•

Depressed tumor growth was noted following

4
eight out of twehty one
able

improvem~nt

thirteen

~!ture the~apy

trials • question•

being noted in six of the remaining

tr-ial~ •..

and no discernible change following

seven of the treatments.

Only one out of five patients

· hav:f:ng multiple treatments demonstrated no improvement . ,.
at any time.
The search for a molecule which tvas preferentially
absol~bed

by cancer•ous ·bissue and to which boron could. be

attached was implemented in, 1957 vthen Rall, et al (13}
:beported the appearance and persistence of fluorescent.
material in tumo:r tissue following administration of the
tetracycline

compounds~

Since the tetracycline

con~ounds

were round to be present in tumor tissue for as long as
twenty one days following injection it was apparent that
tetracycline had the potential of acting as the vehicle
which would earry

bo~on•lO

to ' the cancerous
'

tissue~

Of

even greater importance than this discovery was the fact
that tetracycline could not be detected in normal tissue
f'orty eight hours

afte:~:J

the tetracycline administration•

The absorption of tetracycline has been noted in,oarcinomas,
sa!'oonu:ts, and some lymphomas, but 1t is apparently not

absorbed by melanomas ..
The objeotiveof' this study is the preparation
of a

te~!"aoycline•boron-.10

derivative which is stable

under biological conditions.

The bor-on ... lO should then

provide a concentration of material capable of accepting

1I

I

thermal neutrons, thus producing localized higkl.•energy
alpha radiation.

The ff16t that the tetracyclines

are not

. ~etained. by norrrial 'Cis sue should :remove· the danger of
destruction of thi$ ti.ssue.

. OHAP'l'E:H · II

.EXPERIMENTAL

MatElllic lithium will replace aromatic_ halogens
.

under

.

proper conditions (14).·

7""chlorotetraoycline was selected as the moat suitable
starting :material for the preparation of a boron-tetra-

cycline compound through the aryl lithium intermediatae

c 1-13

'N

cl-13
/

OH

c~o

OH

0

"NH

+ 7 L.A.

(1s)

"
CH3

'N'

CJ-1.3

OL..i

+2:~H~ +

,,
Ol.A.

Ol...A.

0

c?o
"NH 2..

)

L~C1

7

®
Aureomyo:ln neutral

base, rather than Aureomycin

hydrochloride, was selected as the starting .material
because of the reactivity of the chlor-ide ion with lithiume
Solubilty studies of 7•chlorotetracyolina showed
maximum solubilities .ot

.15

mg/.ml, or less, in benzene,

nitrobenzene, ethyl acetate, toluene, chloroform, cyclo•
hexane and d.iathyl ether at 25°0 and 14.9 mg/ml in tetra•
hydroturan and dioxane at 25 9 C.

Reddish gum•like

materials, indicating ohem:lcal change, were obtained on
evaporation of the dioxane solution; thus tetrahydrofurari
was chosen as the most promising solvent for the study of
the replacemen·t of the he.logen by lithium.

The :t'1rst step in the synthesis of tetracycline ..
7•boronic acid was the preparation of 7·1i thium tetra•
cyoline.

'7·45 grams

o.t'

Aweo:myc:tn, Neutral, 4ll5Bl6•1,

lot number 7•910.5. suppl.ied by tederle Laboratories
Division, American Cynamid o'ompany, was di:·saolved in five
hundred millili tarsi of' anhydrous ·hetrahydrofl.Wan and
passed ovet> pea

sh~ed

pieces or metallic lithium in a
'

glass reaction vessel thirty centimeters by one centimeter.
The lithium metal was held in place by a constriction at
the lower end of ·the tuba and a cotton plug at the upper
end of the column containing the metallic li"l;hium•
Oaloium chloride tubes were built into the apparatus to
prevent atmospheric moisture

hydroly~ing

the 7•lithium

tetracycline •. The solution was passed through the lithium

8
column by g:ravtty flow.· Adjustment of the rate of f'lo't.Y
of the solution wa.s made by a stopcock and adjusted to

five hundred milliliters o:f'. solution per hotW.
glass filter was

in~talled

A sintered

below .the reaction vessel to

remove insoluble materials; chiefly 1ithil.lrt1 chloride,
formed·dl,.'Wing the reaction.

A diagram of' the apparatus

used appears in figure 1.
One hundred milliliters of an anhydrous saturated
solution of boric acid in tetrahydx•ofuran (12.3 :mg/ml)

-was placed in a one l:tte:r rouhd botto1n flask fitted with
a refluxcondense:r> and protected from moisture by a
calcium. chloride tube.

The tetrahyd:roturan solution of

7•lithium tetracycline was added and the resulting
solution .refluxed for· trwee hours •.

oL..t.

II

Qli. 0

OL.t.

el-l~ ;-cH~.

Ho

oH
'8" c.f-1:~.

N

OLA.

Oli.

+ L.i- 01-.1
C.~o

OLi..

I

OL~

"NH 2..

9
Precipitation of'

tet:racyclin~ ... 7·boronic

sol~bil:tty

presumably due . to dif'fe:rel;),ces .in the

ohlorotetJ?acycline and
tetrahydrofur-e.rh

acid occurred,

tetracycli.n~-7·bpronic

7'7chlorotetracy~line

of' 7•

.· ac.id in

has a. maximum

solubility of 14.•9 mg/ral in tetrahydrofuran at 2,5°C,

whereas tetraoycline•7·boron:i.c acid has a maxi:mt.un solubil:J. ty

of' only 7.6 mg/ml in tetrahydrof'ura.n at 25°0 and 6.9 mg/ml

----

tn-boiTing tetre.hydrofuran (66°0).

The mixtur'e of' solids containing boric ac::J.d,
lithium borate and tetra.cycline.;,.7•boronic a.cid was
filtered by suction at

66°C~

The subt:rliances on the filter

were washed with cold absolute ethanolto remove boric
acid and lithium borate.

The remaining crude tetra•

oycline•7•boronic acid was dried

!!!

v.aouo (yield

48.4%

theoretical).
The crude tetracyclina-7•boronio acid was a yellow
material which analyzed..a maxitnum of

1•84.%

boron. ·

Oal~ulated :f'oJ? tetra.cycline•7•boron:to acid is 2.21.1.%•

The method of boron analysis is discussed in a later

section of this chapter•
Alkali fusion of the tetracyclines has been shown
by :Pasternao.k (16) to yield both derivatives of salicyolio

acid and m•hydroxybenzoic acid from the left hand ring
of the tetracycline molecule.

Thus by anology with

Pasternack) a result) the degradation of tetracycline•? ...
boronic a.o id by e.lkali fusion rnay be expected to proceed

10

as follows:

Ol--i...

+

Degradation Products

(_ -;::0

oi-l
st~rio

'oH
hindrance should prevent the formation of

4-hydroxy•l•boro•ben~oio

acid.

Following closely the method used by Pasternack
to isolate salioyclic ·acid, an attempt was made to isolate
$•borosalicylic acid.

12•5 grams or tetracycline-?•

boJ;>onic acid were added portionwise over one half hour

to a melt of sixty .grams of potassium hydroxide and thi:roty
gPantS

of sodiurrl hydroxide at 200° to 210°0.

After one

hour of futhur heating the melt was cooled, dissolved in
two hundred milliliters of water.· acidified with. 50%
h~drochloric

acid and extracted with three seventy five

:milliliter portions of ethyl acetate.

'

------

The ethyl acetate

11

extract was evaporated to dryness and the black tarry
product sublimed at 200°0 (l:mm.) to yield 1.08 grams of
brownish oily crystals.
Treatment of an aqueous solution of the sublimed
material with activated charcoal did not remove all the
colored impurities pl:'lesant in a single treatment.

A

second a.ctiva.ted oh.a.rcoal treatment and .t"ractional

crystallization of the material from water yielded
approximately twenty milligrams of white crystals with
a melting point of 158° to 159°0 and .0624 grams of a
brownish crystalline material with a melting point of
169° to 180°c.

The crystalline material which showed a

melting point of 158<•, to 159°0, when mixed with an
authentic sample of salicylic acid)did not depress the
melting point$

The brownish crystalline material could

not be purified. further d'q.e to the small amount present.
The brownish crystalline material has been studied
and the following evidence indicates 'lihe presence of a
carbon-boron

bond~

Under. the conditions of the sublimation

of the fusion products, as outlined by Pasternack (16),
boric acid will not sublime.

Alkali fusion and acidifi•

I!
I

'cation of ·che tetl?acyolina-?•boronic acid would likely
produce boric ao:td unless a oarbon•boron bond were present.
~

The sublimed material when subjected to flame photometrio
analysis shows a strong boron emission band bett'lfeen .548..1'M ..t..L.-

and

566~,

"

12
Methyl borate has been extensively used in the

Many

detection and determination of boron as, bovic acid.
methods have. beeh proposed in which the boric acid is

separated from acoorapa:n:y:tng substru1ces by converting to .

the volatile methyl borate and distilling {17•23).

The

distille:lie can be subjected to flame photometric methods
of analysis (24).
The samples of tetraoycline•7-bor.onic acid were
analysed for boron content• by the following procedure.
The samples 'tve:re digested with four milliliters of boron
. free concentrated sulfuric acid in a two hundred and fifty

milliliter flask mod:i.fied for either r•eflux or distillation.
Tenmilliliters of boron free methanol was added Md the

mixtm-ae refluxed for fifteen minutes, pivoted to the
distillation position and the solution distilled to a
tempevatm~e

of· 70 6 0.

Ten rnillili ters of :methanol was

·added to the distillation flask and the solution again

distilled to 70°0•

A final

ten milliliters of methanol

was added to the distillation flask and the solution

distilled to a volume of twenty five milliliters-

The

distillate obtained was subjected to .fltame photometric
a.nalysis

and

compared to a

the same method.

stand~d

which was prepared by

The standard was prepared by plotting

the log of the optical density versus the concentration
of boron in micrograms per millilitero

A flame attachment

with a Beckman model B spectophotometer was used in the

13
studies.
Presence of sodium in the

borate results in higher
boron· emission

sp~et:rum.

optic~l

(24.).

I.t

dist:i.llat~

of methyl

density readings of the

was found that a

o?noentrat:ton of one microgram; or less., of sodium per

milliliter did not cause error in the boron analysis.
f----~~~-----"B"-'-a----'f_f_::l_c_e_plates

:built into the distillation flask

PRJ~ve_nj;~d..~~~__:___

spray 1 . oonta:i.ning sodium, being carried over into the
distillate.

figure 2,.

A diagram of the

~pparatua

used appears in

14
.FIGURE l
DIAGRAM OF THE APPARATtTS USED :POR Tim PREPARATION OF

7•LITHIUM TETRACYCLINE

A

F

A)

D~ying

ll)

Inlet fo:r the 7•ohlorotet:racyeline•tetrahydrof'uren
solution

0)

Stopcock

D)

Metallic lithium reaction vessel

E)

Sintered glass filte:r>

F)

Collection flask

tube
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F'IGURE 2
. :biAGRA~l OF THE APPARATUS USED FOR BORON DETERMINATION

A)

Reaction and distillation flask

·B)

Baffle plates

0)

Inlet

D)

Thermometer

E)

Water cooled Qondenser

F)

Ice cooled trap

G)

Volumetric flask

H)

Pivot for setting the apparatus in either reflux or
distillation position

f.~r

acid and

:m,~thanol

,

OHAPTF.m III
DISCUSSION

The presence

of

chloride ion in the insoluble

residue from the lith:tu.:m meta1""7-ohlorotetracycline
reaction has shown the successful removal of the chlorine.
Replacement of the li·bhium by boric aoid is not described
;tn-th~e-J:tt-erature;. lloweve~:~rt-was-incfioatea-by-aho:ron

emission band present in flame.photomat:ric analysis of the
alkali fusion products of tetracyeline..-7-boron:to ao:td.
5-borosalioyolio acid" which may be one of the
degradation products of alkali fusion of tetracycline•7boronio acid is not described in the literature; however,
the synthesis of the compound is being attempted at
College of the Pacific.
Futher studies are suggested in the areas of better
methods of synthesis of

tetraoycline·7~boronio

acid,

preventing gum•like mate:r:tal f'orming and studies of the

t:Wyl-.lithiu.m-borie acid

reaction~

It is evident that the

. above problems which exist must be completed before an

absolute p.repa.vation of tet:raoycline...,7•bo.ronio acid n1ay
be claimed.

~~------~-~
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